4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-076049
Chairman & CEO bought 4,000 shares at an average $11.64 ($46,540)
From the SEC's structured data for this filing
Trades in this filing
BENTSUR RON · Chairman & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-28 | Purchase : show line 1 in the form | +300 | $11.82 | $3,546 | 2,964,614 | D |
| 2022-06-29 | Purchase : show line 2 in the form | +3,700 | $11.62 | $42,994 | 2,968,314 | D |
| Open-market purchases · 4,000 sh · avg $11.64 · $46,540 | ||||||
Loading xslF345X03/tm2220119-1_4seq1.xml…